Logo image of TLRY

TILRAY BRANDS INC (TLRY) Stock Price, Forecast & Analysis

USA - NASDAQ:TLRY - US88688T1007 - Common Stock

1.23 USD
+0.02 (+1.65%)
Last: 11/7/2025, 3:26:58 PM

TLRY Key Statistics, Chart & Performance

Key Statistics
Market Cap1.38B
Revenue(TTM)821.31M
Net Income(TTM)-2.19B
Shares1.12B
Float1.11B
52 Week High2.32
52 Week Low0.35
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-1.5
PEN/A
Fwd PEN/A
Earnings (Next)01-08 2026-01-08/bmo
IPO2018-07-19
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals


TLRY short term performance overview.The bars show the price performance of TLRY in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 50 100 150

TLRY long term performance overview.The bars show the price performance of TLRY in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60

The current stock price of TLRY is 1.23 USD. In the past month the price decreased by -42.38%. In the past year, price decreased by -18.79%.

TILRAY BRANDS INC / TLRY Daily stock chart

TLRY Latest News, Press Relases and Analysis

TLRY Competitors/Peers

The largest stocks on the US markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
LLY ELI LILLY & CO41.72868.27B
JNJ JOHNSON & JOHNSON17.98449.44B
MRK MERCK & CO. INC.9.77214.88B
PFE PFIZER INC7.62138.67B
BMY BRISTOL-MYERS SQUIBB CO7.1395.14B
ZTS ZOETIS INC18.9353.19B
RPRX ROYALTY PHARMA PLC- CL A9.3722.45B
VTRS VIATRIS INC4.3111.71B
ELAN ELANCO ANIMAL HEALTH INC22.3310.65B
CORT CORCEPT THERAPEUTICS INC82.187.62B
AXSM AXSOME THERAPEUTICS INCN/A6.88B
CRNX CRINETICS PHARMACEUTICALS INN/A3.76B

About TLRY

Company Profile

TLRY logo image Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. The company is headquartered in Leamington, Ontario and currently employs 2,842 full-time employees. The company went IPO on 2018-07-19. The firm operates through four segments: Cannabis operations, Distribution business, Beverage alcohol business and Wellness business. The Cannabis operations, which encompasses the production, distribution, sale, co-manufacturing and advisory services of both medical and adult-use cannabis. The Beverage alcohol operations, which encompasses the production, marketing and sale of beverage alcohol products. The Distribution operations, which encompasses the purchase and resale of pharmaceuticals products to customers. The Wellness products, which encompasses hemp foods and cannabidiol (CBD) products. The firm offers a portfolio of adult-use brands and products and expands its portfolio to include new cannabis products and formats. Its brands include Good Supply, RIFF, Broken Coast, Solei, Canaca, HEXO, Redecan, Original Stash, Hop Valley, Revolver, Bake Sale, XMG, Mollo, and others.

Company Info

TILRAY BRANDS INC

265 Talbot Street West

Leamington ONTARIO V9X 1J2 CA

CEO: Irwin D. Simon

Employees: 2842

TLRY Company Website

TLRY Investor Relations

Phone: 15193228800

TILRAY BRANDS INC / TLRY FAQ

Can you describe the business of TILRAY BRANDS INC?

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. The company is headquartered in Leamington, Ontario and currently employs 2,842 full-time employees. The company went IPO on 2018-07-19. The firm operates through four segments: Cannabis operations, Distribution business, Beverage alcohol business and Wellness business. The Cannabis operations, which encompasses the production, distribution, sale, co-manufacturing and advisory services of both medical and adult-use cannabis. The Beverage alcohol operations, which encompasses the production, marketing and sale of beverage alcohol products. The Distribution operations, which encompasses the purchase and resale of pharmaceuticals products to customers. The Wellness products, which encompasses hemp foods and cannabidiol (CBD) products. The firm offers a portfolio of adult-use brands and products and expands its portfolio to include new cannabis products and formats. Its brands include Good Supply, RIFF, Broken Coast, Solei, Canaca, HEXO, Redecan, Original Stash, Hop Valley, Revolver, Bake Sale, XMG, Mollo, and others.


What is the stock price of TILRAY BRANDS INC today?

The current stock price of TLRY is 1.23 USD. The price increased by 1.65% in the last trading session.


Does TILRAY BRANDS INC pay dividends?

TLRY does not pay a dividend.


What is the ChartMill technical and fundamental rating of TLRY stock?

TLRY has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 2 out of 10.


What sector and industry does TILRAY BRANDS INC belong to?

TILRAY BRANDS INC (TLRY) operates in the Health Care sector and the Pharmaceuticals industry.


What is TILRAY BRANDS INC worth?

TILRAY BRANDS INC (TLRY) has a market capitalization of 1.38B USD. This makes TLRY a Small Cap stock.


What is the next earnings date for TLRY stock?

TILRAY BRANDS INC (TLRY) will report earnings on 2026-01-08, before the market open.


TLRY Technical Analysis

ChartMill assigns a technical rating of 4 / 10 to TLRY. When comparing the yearly performance of all stocks, TLRY is one of the better performing stocks in the market, outperforming 89.61% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

TLRY Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to TLRY. TLRY has a bad profitability rating. Also its financial health evaluation is rather negative.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

TLRY Financial Highlights

Over the last trailing twelve months TLRY reported a non-GAAP Earnings per Share(EPS) of -1.5. The EPS decreased by -648% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -105.42%
ROE -144.68%
Debt/Equity 0.19
Chartmill High Growth Momentum
EPS Q2Q%100%
Sales Q2Q%4.73%
EPS 1Y (TTM)-648%
Revenue 1Y (TTM)4.1%

TLRY Forecast & Estimates

16 analysts have analysed TLRY and the average price target is 1.89 USD. This implies a price increase of 53.69% is expected in the next year compared to the current price of 1.23.

For the next year, analysts expect an EPS growth of 97.18% and a revenue growth 3.64% for TLRY


Analysts
Analysts72.5
Price Target1.89 (53.66%)
EPS Next Y97.18%
Revenue Next Year3.64%

TLRY Ownership

Ownership
Inst Owners9.86%
Ins Owners0.36%
Short Float %9.41%
Short Ratio1.32